Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nexus Ingredient is a global specialist in the development and supply of functional, clean-label ingredients for the food, beverage, and nutraceutical sectors. The company focuses on innovative solutions for sugar reduction and fiber enrichment, utilizing advanced enzymatic processes to produce prebiotic fibers and rare sugars. Their product portfolio includes isomalto-oligosaccharides (IMO), tagatose, and allulose, designed to support metabolic and digestive health. Headquartered in Australia with a significant presence in the United States, Nexus Ingredient provides technical expertise to manufacturers seeking to enhance nutritional profiles while maintaining sensory quality. Their offerings are characterized by being non-GMO, gluten-free, and allergen-friendly, catering to the growing demand for health-conscious food formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nexus Ingredient.